KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Novavax (NVAX) Income from Continuing Operations (2016 - 2025)

Novavax (NVAX) has 16 years of Income from Continuing Operations data on record, last reported at 17527000.0 in Q4 2025.

  • For Q4 2025, Income from Continuing Operations rose 121.63% year-over-year to 17527000.0; the TTM value through Dec 2025 reached 440302000.0, up 334.83%, while the annual FY2025 figure was 440302000.0, 334.83% up from the prior year.
  • Income from Continuing Operations reached 17527000.0 in Q4 2025 per NVAX's latest filing, up from 202379000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 518646000.0 in Q1 2025 and bottomed at 846284000.0 in Q4 2021.
  • Average Income from Continuing Operations over 5 years is 134697450.0, with a median of 158081500.0 recorded in 2022.
  • Peak YoY movement for Income from Continuing Operations: crashed 1910.83% in 2021, then soared 451.51% in 2025.
  • A 5-year view of Income from Continuing Operations shows it stood at 846284000.0 in 2021, then surged by 78.46% to 182249000.0 in 2022, then rose by 2.12% to 178389000.0 in 2023, then skyrocketed by 54.58% to 81030000.0 in 2024, then skyrocketed by 121.63% to 17527000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Income from Continuing Operations were 17527000.0 in Q4 2025, 202379000.0 in Q3 2025, and 106508000.0 in Q2 2025.